524742 Stock Overview
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 6/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Caplin Point Laboratories Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹1,334.20 |
52 Week High | ₹1,617.80 |
52 Week Low | ₹647.10 |
Beta | 0.38 |
1 Month Change | 5.23% |
3 Month Change | -9.68% |
1 Year Change | 103.65% |
3 Year Change | 167.16% |
5 Year Change | 266.84% |
Change since IPO | 606,354.55% |
Recent News & Updates
Recent updates
Shareholder Returns
524742 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 1.3% | -1.4% | -1.6% |
1Y | 103.6% | 53.7% | 45.0% |
Return vs Industry: 524742 exceeded the Indian Pharmaceuticals industry which returned 53.7% over the past year.
Return vs Market: 524742 exceeded the Indian Market which returned 45% over the past year.
Price Volatility
524742 volatility | |
---|---|
524742 Average Weekly Movement | 4.5% |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524742 has not had significant price volatility in the past 3 months.
Volatility Over Time: 524742's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1990 | 1,642 | Sridhar Ganesan | www.caplinpoint.net |
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. It provides liquid and lyophilized vials, pre-filled syringes, 3-pc ophthalmic droppers, pre-mix bags, dry and liquid syrups-bottles, tables, soft gels, capsules, suppositories, liquid and emulsion injectables in ampoules and vials, topicals, and sachets. The company was incorporated in 1990 and is headquartered in Chennai, India.
Caplin Point Laboratories Limited Fundamentals Summary
524742 fundamental statistics | |
---|---|
Market cap | ₹101.32b |
Earnings (TTM) | ₹4.38b |
Revenue (TTM) | ₹16.32b |
23.2x
P/E Ratio6.2x
P/S RatioIs 524742 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
524742 income statement (TTM) | |
---|---|
Revenue | ₹16.32b |
Cost of Revenue | ₹7.25b |
Gross Profit | ₹9.06b |
Other Expenses | ₹4.69b |
Earnings | ₹4.38b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 57.62 |
Gross Margin | 55.55% |
Net Profit Margin | 26.82% |
Debt/Equity Ratio | 0.2% |
How did 524742 perform over the long term?
See historical performance and comparison